← Product Code [NFB](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/NFB) · K961126 # PULSE DOSE SERIES (K961126) _Devilbiss Health Care, Inc. · NFB · Oct 21, 1996 · Anesthesiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/NFB/K961126 ## Device Facts - **Applicant:** Devilbiss Health Care, Inc. - **Product Code:** [NFB](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/NFB.md) - **Decision Date:** Oct 21, 1996 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 868.5905 - **Device Class:** Class 2 - **Review Panel:** Anesthesiology - **Attributes:** Therapeutic ## Indications for Use The devices assist patients, who require prescribed doses of supplemental gases such as oxygen, to conserve gas from the various gaseous cylinders or liquid oxygen reservoirs. By allowing oxygen to flow only from the cylinder or liquid oxygen reservoirs during the inspiratory segment of a patient's breathing cycle, conservation occurs. ## Device Story Pulse Dose Series oxygen management system; provides bolus of oxygen at start of inhalation; conserves gas by restricting flow to inspiratory phase of breathing cycle; battery-powered; includes battery level indicator; microprocessor-controlled; repackaged version of OMS 20 and 50; intended for patient use to improve oxygen delivery efficiency and device usability. ## Clinical Evidence Bench testing only. Comparison of dosage delivery between Pulse Dose Series and predicate devices (OMS 20/50) confirms identical performance. ## Technological Characteristics Battery-powered; microprocessor-controlled; pneumatic oxygen delivery system; includes battery level indicator; repackaged for improved cosmetics and assembly. ## Regulatory Identification A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing. ## Predicate Devices - OMS 20 - OMS 50 ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} 10/09/96 WED 14:25 FAX 814 443 7571 DeVILBISS ENGINEERING 003 DeVILBISS a division of SUNRISE MEDICAL DeVilbiss Health Care, Inc. 1200 East Main Street P.O. Box 635 Somerset, PA 15501-0635 U.S.A. (814) 443-4881 Fax: (814) 443-7572 K961126 OCT 21 1996 # 16.0 510 (k) Summary ## Summary of Safety and Effectiveness **Firms name:** DeVilbiss Health Care, Inc. Pulsair Division P.O. Box 2609 4106 Avenue D Fort Pierce, Fla. 34954 **Submitter's name:** Gregory W. Good **Phone:** (814) 443-7466 **Fax:** (814) 443-7571 **Date of Preparation:** 9 October 1996 **Trade name:** Oxygen Management Systems **Common name:** Pulse Dose Series **Classification name:** Non-Continuous Ventilators 73BZD (21 CFR 868.5905) The Pulse Dose Series devices are fundamentally repackaged versions of the OMS 20 and 50, DeVilbiss' current Oxygen Management Systems. The devices provide a bolus of oxygen to a patient at the start of inhalation. The devices assist patients, who require prescribed doses of supplemental gases such as oxygen, to conserve gas from the various gaseous cylinders or liquid oxygen reservoirs. By allowing oxygen to flow only from the cylinder or liquid oxygen reservoirs during the inspiratory segment of a patient's breathing cycle, conservation occurs. The gas dosage methodology, oxygen delivery specifications, and performance of the devices in the Pulse Dose Series are identical to those of the OMS 20 and 50. This is evidenced in the various comparison matrices and testing reports contained in this 510(k). This equivalency is also evidenced in the non-clinical testing which reveals the same dosage delivery when comparing the predicate devices with the devices in the Pulse Dose Series. The device's performance to the end user are identical as compared to the OMS 20 and 50. Exhibit 1A {1} 10/09/96 WED 14:26 FAX 814 443 7571 DeVILBISS ENGINEERING 004 When compared to the predicate devices, the OMS 20 and 50, the devices in the Pulse Dose Series utilize the same type of energy source, and there are no significant changes in the materials or features. All the devices in the Pulse Dose series utilize batteries as the energy source, as do the OMS 20 and 50. The fundamental operational features are identical; however, the devices in the Pulse Dose Series include some additional features, e.g., battery level indicator, which make the devices more user friendly. The differences between the devices in the Pulse Dose Series and the OMS 20 and 50 can be categorized as additional patient features (battery level indicator), technological improvements (microprocessor control), or re-packaging (improved cosmetics and manufacturing / servicing assembly). Tests and analysis indicate that there is no greater risk to the end user than there is with the predicate devices. These device improvements were intended to make the devices in the Pulse Dose Series more user friendly while increasing their reliability, without altering their performance for the end user. Therefore, based on the above mentioned similarities, especially the dosage methodology, the Pulse Dose Series devices and the OMS 20 and 50 are substantially equivalent devices. Exhibit 1A (cont.) --- **Source:** [https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/NFB/K961126](https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/NFB/K961126) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com